SOPHARMA (SPH): Sopharma monthly October 2012 - raport 111
Raport ESPI
UNI - EN REPORT No 111/2012
Podstawa prawna:
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
The Board of Directors of Sopharma AD (the "Company") notifies that for October 2012 Sopharma AD realized decrease of sales revenues of 2% compared to the same period of 2011, including 10% decrease of domestic sales and 2% increase of export sales.
During the first ten months of this year Sopharma AD realized an increase of sales revenues of 2%, including 10% decrease of domestic sales and 7% increase of export sales compared to the same period of 2011.
Annexes:
File;
